Hypoxia and the extracellular matrix: drivers of tumour metastasis - PubMed (original) (raw)
Review
Hypoxia and the extracellular matrix: drivers of tumour metastasis
Daniele M Gilkes et al. Nat Rev Cancer. 2014 Jun.
Abstract
Of the deaths attributed to cancer, 90% are due to metastasis, and treatments that prevent or cure metastasis remain elusive. Emerging data indicate that hypoxia and the extracellular matrix (ECM) might have crucial roles in metastasis. During tumour evolution, changes in the composition and the overall content of the ECM reflect both its biophysical and biological properties and these strongly influence tumour and stromal cell properties, such as proliferation and motility. Originally thought of as independent contributors to metastatic spread, recent studies have established a direct link between hypoxia and the composition and the organization of the ECM, which suggests a new model in which multiple microenvironmental signals might converge to synergistically influence metastatic outcome.
Conflict of interest statement
Competing interests statement
The authors declare no competing interests.
Figures
Figure 1. Biosynthesis of fibrillar collagens
The biosynthesis of type I collagen and other fibrillar collagens can be divided into intracellular (parts a–c) and extracellular (parts d–f) steps. The first intracellular step involves the synthesis of procollagen polypeptides from any of 42 distinct collagen gene transcripts (part a). Procollagens are post-translationally modified within the cisternae of the endoplasmic reticulum (ER) by prolyl 4-hydroxylase α-subunit isoform 1 (P4HA1), P4HA2 and P4HA3 and by procollagen-lysine 2-oxyglutarate 5-dioxygenase 1 (PLOD1), PLOD2 and PLOD3 lysyl hydroxylase enzymes (part b). Hydrolysine residues can be further modified to galactosyl hydroxylysine and to glucosylgalactosyl hydroxylysine by collagen galactosyltransferase and glucosyltransferase, respectively. The carboxyl termini of three properly hydroxylated procollagen molecules will associate and spontaneously propagate a procollagen triple helix from the carboxyl terminus to the amino terminus. The triple helical procollagen will be transported from the ER to the extracellular space via the Golgi (part c). Two metalloproteinases, a procollagen N-terminal proteinase and a procollagen C-terminal proteinase, cleave the non-helical termini (part d) and the mature collagen proteins spontaneously aggregate to form a collagen fibril (part e). The final step, collagen fibre formation, is initiated by collagen crosslinking, which is catalysed by lysyl oxidase (LOX) family members and occurs via the lysine aldehyde- or hydroxylysine aldehyde-initiated pathway (part f). The number and the proportion of the various crosslinks are tissue specific and are regulated by the steric relationship between localized collagen molecules, the type of collagens co-polymerized and the glycosylation and the hydroxylation of the participating amino acid residues. For example, lysine aldehyde-initiated crosslinks are found in soft connective tissue, in contrast to hydroxylysine aldehyde-initiated crosslinks, which are found in stiff connective tissues. Many non-fibrillar collagens retain a non-collagenous N- or C-terminal, which prevents the spontaneous formation of collagen fibrils, and in these collagens cysteine crosslinks might be the only source of covalent intermolecular bonds. Enzymes highlighted in red are induced under hypoxic conditions. LOXL, LOX-like protein.
Figure 2. Hypoxia promotes ECM remodelling to facilitate metastasis
Extracellular matrix (ECM) remodelling is tightly controlled to maintain tissue integrity. Cancer cells and associated stromal cells that have been exposed to hypoxia are transcriptionally reprogrammed to produce: matrix metalloproteinases (MMPs) and other proteases, which degrade the basement membrane surrounding a tumour (part a); aligned collagen fibres within the interstitial matrix, which function as a highway for local invasion, intravasation and metastasis (part b); and growth factors, which might be retained in the fibrotic microenvironment and function as chemotactic signals that recruit and activate stromal cells to further promote cancer progression (part c).
Figure 3. Hypoxia recruits and reprogrammes cells to produce fibrillar collagen
Hypoxia-induced and hypoxia-inducible factor (HIF)-regulated growth factor secretion by tumour cells promotes the recruitment of macrophages and fibroblasts to hypoxic regions of the primary tumour. Macrophages produce growth factors such as transforming growth factor β1 (TGFβ1) and platelet-derived growth factor (PDGF) that activate recruited and resident fibroblasts to stimulate collagen deposition. Hypoxic cancer cells also signal to mesenchymal stem cells, which might participate in collagen deposition. HIFs regulate the production of collagen-modifying enzymes, including prolyl 4-hydroxylase α-subunit isoform 1 (P4HA1), P4HA2, procollagen-lysine 2-oxyglutarate 5-dioxygenase 2 (PLOD2), lysyl oxidase (LOX), LOX-like protein 2 (LOXL2) and LOXL4 to facilitate the proper maturation of collagen fibres. Together, these signalling pathways promote the production of a fibrillar collagen network (that is produced by multiple cell types), which increases the ability of cancer cells to invade blood vessels. BMDSCs, bone marrow-derived stem cells; ECM, extracellular matrix.
Similar articles
- Charting the unexplored extracellular matrix in cancer.
Filipe EC, Chitty JL, Cox TR. Filipe EC, et al. Int J Exp Pathol. 2018 Apr;99(2):58-76. doi: 10.1111/iep.12269. Epub 2018 Apr 19. Int J Exp Pathol. 2018. PMID: 29671911 Free PMC article. Review. - Hypoxic regulation of metastasis via hypoxia-inducible factors.
Gort EH, Groot AJ, van der Wall E, van Diest PJ, Vooijs MA. Gort EH, et al. Curr Mol Med. 2008 Feb;8(1):60-7. doi: 10.2174/156652408783565568. Curr Mol Med. 2008. PMID: 18289014 Review. - The interplay between extracellular matrix remodelling and kinase signalling in cancer progression and metastasis.
Skhinas JN, Cox TR. Skhinas JN, et al. Cell Adh Migr. 2018;12(6):529-537. doi: 10.1080/19336918.2017.1405208. Epub 2017 Dec 29. Cell Adh Migr. 2018. PMID: 29168660 Free PMC article. Review. - Dynamic matrisome: ECM remodeling factors licensing cancer progression and metastasis.
Yuzhalin AE, Lim SY, Kutikhin AG, Gordon-Weeks AN. Yuzhalin AE, et al. Biochim Biophys Acta Rev Cancer. 2018 Dec;1870(2):207-228. doi: 10.1016/j.bbcan.2018.09.002. Epub 2018 Oct 12. Biochim Biophys Acta Rev Cancer. 2018. PMID: 30316942 Review. - Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth.
Barkan D, Green JE, Chambers AF. Barkan D, et al. Eur J Cancer. 2010 May;46(7):1181-8. doi: 10.1016/j.ejca.2010.02.027. Epub 2010 Mar 19. Eur J Cancer. 2010. PMID: 20304630 Free PMC article. Review.
Cited by
- Pancreatic tumor microenvironmental acidosis and hypoxia transform gold nanorods into cell-penetrant particles for potent radiosensitization.
Rauta PR, Mackeyev Y, Sanders K, Kim JBK, Gonzalez VV, Zahra Y, Shohayeb MA, Abousaida B, Vijay GV, Tezcan O, Derry P, Liopo AV, Zubarev ER, Carter R, Singh P, Krishnan S. Rauta PR, et al. Sci Adv. 2022 Nov 11;8(45):eabm9729. doi: 10.1126/sciadv.abm9729. Epub 2022 Nov 11. Sci Adv. 2022. PMID: 36367938 Free PMC article. - Exploring doxorubicin transport in 2D and 3D models of MDA-MB-231 sublines: impact of hypoxia and cellular heterogeneity on doxorubicin accumulation in cells.
Januškevičienė I, Petrikaitė V. Januškevičienė I, et al. Am J Cancer Res. 2024 Jul 15;14(7):3584-3599. doi: 10.62347/VNWH9165. eCollection 2024. Am J Cancer Res. 2024. PMID: 39113879 Free PMC article. - Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma.
Eckert AW, Wickenhauser C, Salins PC, Kappler M, Bukur J, Seliger B. Eckert AW, et al. J Transl Med. 2016 Apr 5;14:85. doi: 10.1186/s12967-016-0828-6. J Transl Med. 2016. PMID: 27044404 Free PMC article. Review. - Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment.
Zhang F, Guo J, Yu S, Zheng Y, Duan M, Zhao L, Wang Y, Yang Z, Jiang X. Zhang F, et al. Cancer Commun (Lond). 2024 Sep;44(9):929-966. doi: 10.1002/cac2.12591. Epub 2024 Jul 12. Cancer Commun (Lond). 2024. PMID: 38997794 Free PMC article. Review. - Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis.
Ziegler YS, Moresco JJ, Yates JR 3rd, Nardulli AM. Ziegler YS, et al. PLoS One. 2016 Jun 29;11(6):e0158296. doi: 10.1371/journal.pone.0158296. eCollection 2016. PLoS One. 2016. PMID: 27355404 Free PMC article.
References
- Vaupel P, Mayer A, Hockel M. Tumour hypoxia and malignant progression. Methods Enzymol. 2004;381:335–354. - PubMed
- Sorg BS, Hardee ME, Agarwal N, Moeller BJ, Dewhirst MW. Spectral imaging facilitates visualization and measurements of unstable and abnormal microvascular oxygen transport in tumours. J Biomed Opt. 2008;13:014026. - PubMed
- Vaupel P. Prognostic potential of the pre-therapeutic tumour oxygenation status. Adv Exp Med Biol. 2009;645:241–246. - PubMed
- Vaupel P, Hockel M, Mayer A. Detection and characterization of tumour hypoxia using pO2 histography. Antioxid Redox Signal. 2007;9:1221–1235. - PubMed
- Semenza GL. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol. 2014;9:47–71. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases